Global Herpes Market 2014-2018

ヘルペス治療薬の世界市場:口唇ヘルペス、陰部ヘルペス

◆タイトル:Global Herpes Market 2014-2018
◆商品コード:IRTNTR4662
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年12月3日
◆ページ数:67
◆資料形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥313,600見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD3,500 ⇒換算¥392,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

当調査レポートでは、ヘルペス治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、ヘルペス治療薬の世界市場規模及び予測、種類別分析、製品別分析、市場シェア、地域別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。

About Herpes
Generally, herpes covers two different diseases: oral herpes, also known as cold sores and genital herpes. While oral herpes affects the area around the mouth, genital herpes affects area around the genitals. The HSV-1 causes oral herpes; both HSV-1 and HSV-2 cause genital herpes. HSV is a contagious virus that spread through contact. At present, there is no cure for herpes, however, treatments can help reduce the pain and decrease healing period.

TechNavio’s analysts forecast the Global Herpes market to grow at a CAGR of 10.14 percent over the period 2013-2018.

[Covered in this Report]
This report covers the present scenario and the growth prospects of the Global Herpes market for the period 2013–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs and vaccines used in the treatment and prevention of herpes simplex, herpes zoster and CMV infections that are available in the market.
The report also presents the vendor landscape and a corresponding detailed analysis of the vendors in the Global Herpes market. In addition, the report discusses the major drivers that influence the growth of the market and outlines the challenges faced by the vendors and the market.

[Key Regions]
• Americas
• APAC
• EMEA

[Key Vendors]
• Gilead Sciences
• GSK
• Merck
• Novartis

[Other Prominent Vendors]
• Agenus
• AiCuris
• aRigen Pharmaceuticals
• Astellas Pharma
• CytoGenix
• Epiphany Biosciences
• F. Hoffmann-La Roche
• Genocea Biosciences
• NanoBio

[Market Driver]
• Significant Unmet Needs
• For a full, detailed list, view our report

[Market Challenge]
• Increasing Generic Competition
• For a full, detailed list, view our report

[Market Trend]
• Promising New Launches
• For a full, detailed list, view our report

[Key Questions Answered in this Report]
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【資料の目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings
03.2.1 Product Profiles

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast

07.Competitive Assessment of Marketed Products
07.1 Five Forces Analysis

08.Rate of Incidence and Prevalence
08.1.1 US
08.1.2 UK

09.Diagnosis of Herpes

10.Market Segmentation by Product Type

11.Market Segmentation by Type of Virus

12.Market Assessment of Top Drugs
12.1 Zovirax
12.1.1 Sales
12.2 Valtrex
12.2.1 Sales

13.Geographical Segmentation

14.Buying Criteria

15.Market Growth Drivers

16.Drivers and their Impact

17.Market Challenges

18.Impact of Drivers and Challenges

19.Market Trends

20.Trends and their Impact

21.Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Market Share Analysis 2013
21.3 Other Prominent Vendors

22.Key Vendor Analysis
22.1 Gilead Sciences
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Geographical Segmentation by Revenue 2013
22.1.4 Recent Developments
22.1.5 SWOT Analysis
22.2 GlaxoSmithKline
22.2.1 Key Facts
22.2.2 Business Overview
22.2.3 Business Segmentation
22.2.4 Business Segmentation by Revenue 2012 and 2013
22.2.5 Sales by Geography
22.2.6 Pipeline Products
22.2.7 Business Strategy
22.2.8 Key Information
22.2.9 SWOT Analysis
22.3 Merck & Co. Inc.
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Business Segmentation by Revenue 2013
22.3.4 Business Segmentation by Revenue 2012 and 2013
22.3.5 Sales by Geography
22.3.6 Business Strategy
22.3.7 Key Developments
22.3.8 SWOT Analysis
22.4 Novartis
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Business Segmentation by Revenue 2013
22.4.4 Business Segmentation by Revenue 2012 and 2013
22.4.5 Sales by Geography
22.4.6 Business Strategy
22.4.7 Key Developments
22.4.8 SWOT Analysis

23.Other Reports in this Series

[List of Exhibits]
Exhibit 1: Market Research Methodology
Exhibit 2: Global Herpes Market 2013-2018 (US$ billion)
Exhibit 3: Diagnosis of Herpes
Exhibit 4: Global Herpes Market Segmentation by Type
Exhibit 5: GSK’s Zovirax Revenue 2010-2013 (US$ million)
Exhibit 6: GSK’s Valtrex Revenue 2010-2013 (US$ million)
Exhibit 7: Global Herpes Market by Geographical Segmentation 2013
Exhibit 8: Gilead Sciences: Geographical Segmentation by Revenue 2013
Exhibit 9: GlaxoSmithKline: Business Segmentation 2013
Exhibit 10: GlaxoSmithKline: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 11: GlaxoSmithKline: Sales by Geography 2013
Exhibit 12: GlaxoSmithKline: Pipeline Products 2013
Exhibit 13: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 14: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 15: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 16: Novartis: Business Segmentation by Revenue 2013
Exhibit 17: Novartis: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 18: Novartis: Sales by Geography 2013



【掲載企業】

Gilead Sciences , GSK , Merck , Novartis , Agenus , AiCuris , aRigen Pharmaceuticals, Astellas Pharma, CytoGenix, Epiphany Biosciences, F. Hoffmann-La Roche, Genocea Biosciences, NanoBio

【資料のキーワード】

ヘルペス治療薬、ワクチン、口唇ヘルペス、陰部ヘルペス、製薬、単純ヘルペスウイルス、帯状疱疹、CMV(サイトメガロウイルス)

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[ヘルペス治療薬の世界市場:口唇ヘルペス、陰部ヘルペス] (Global Herpes Market 2014-2018 / IRTNTR4662)販売に関する免責事項
[ヘルペス治療薬の世界市場:口唇ヘルペス、陰部ヘルペス] (Global Herpes Market 2014-2018 / IRTNTR4662)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆